SBIR/STTR Research Award
IGF::OT::IGF: Smokescreen: Genetic Screening Tool for Tobacco Dependence and Treatm
Award amount
$1,000,000Program and phase
SBIR · Phase IIAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOREALM, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- H3WKMCF9V1D3
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
In this SBIR Phase II contract, the contractor shall develop and test Smokescreen for research, specifically, manufacturing the custom genotyping array and software based on specifications gathered in Phase I, and testing and optimizing Smokescreen in diverse smoking-related research applications. PUBLIC HEALTH RELEVANCE
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS (SBIR PHASE II, TOPIC 019)
- SERVICES FOR CREATING A TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS.
- Biosignatures of opioid addiction treatment success
- Smokescreen Translational (TL) Analysis Platform
- Smokescreen Translational (TL) Analysis Platform
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)
Research funding history
8 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $6,217,645. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services